http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108218896-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2018-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108218896-B |
| titleOfInvention | A kind of thiazolopyrimidine HIV-1 reverse transcriptase inhibitor and preparation method and application thereof |
| abstract | The invention relates to a thiazolopyrimidine type HIV-1 reverse transcriptase inhibitor and a preparation method and application thereof. The compound has the structure shown in Formula I or II. The present invention also relates to pharmaceutical compositions containing compounds of formula I or II. The present invention also provides the use of the above-mentioned compounds and compositions containing one or more of such compounds in the manufacture of medicaments for the treatment and prevention of human immunodeficiency virus (HIV). |
| priorityDate | 2018-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.